Nordic Capital to carve out BWXT's medical business in $800m transaction

Nordic expects to scale BWXT's capabilties and market presense in radiopharmaceuticals.

4 August 2026•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.